Pyxis Oncology, Inc. (PYXS) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $9.0K | -96.2% |
| 2024 | $237.0K | -96.5% |
| 2023 | $6.73M | +5.1% |
| 2022 | $6.40M | +1085.0% |
| 2021 | $540.0K | -63.6% |
| 2020 | $1.48M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $9.0K | -96.2% |
| 2024 | $237.0K | -96.5% |
| 2023 | $6.73M | +5.1% |
| 2022 | $6.40M | +1085.0% |
| 2021 | $540.0K | -63.6% |
| 2020 | $1.48M | — |